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Summary
In Williams syndrome (WS), a deletion of ∼1.5 Mb on
one copy of chromosome 7 causes specific physical, cog-
nitive, and behavioral abnormalities. Molecular dissec-
tion of the phenotype may be a route to identification
of genes important in human cognition and behavior.
Among the genes known to be deleted in WS are ELN
(which encodes elastin), LIMK1 (which encodes a pro-
tein tyrosine kinase expressed in the developing brain),
STX1A (which encodes a component of the synaptic ap-
paratus), and FZD3. Study of patients with deletions or
mutations confined to ELN showed that hemizygosity
for elastin is responsible for the cardiological features of
WS. LIMK1 and STX1A are good candidates for cog-
nitive or behavioral aspects of WS. Here we describe
genetic and psychometric testing of patients who have
small deletions within the WS critical region. Our results
suggest that neither LIMK1 hemizygosity (contrary to a
previous report) nor STX1A hemizygosity is likely to
contribute to any part of the WS phenotype, and they
emphasize the importance of such patients for dissecting
subtle but highly penetrant phenotypes.
Introduction
Many human chromosomal-abnormality syndromes in-
clude specific cognitive and behavioral components.
Children with Prader-Willi syndrome, who lack a pa-
ternally derived copy of the proximal long arm of chro-
mosome 15, eat uncontrollably (Sarimski et al. 1996).
People with Smith-Magenis syndrome, caused by a mi-
crodeletion of chromosome 17p11.2, have bizarre and
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specific self-mutilating and aggressive behavior, sleep dis-
turbances, and indifference to pain (Greenberg et al.
1996). A deletion of 22q11 can be associated with ob-
sessive behavior and schizophreniform disorders (Ryan
et al. 1997). Identification of the genes located on the
relevant chromosomal segments may allow us to char-
acterize genes that contribute to specific features of hu-
man cognition and behavior.
This strategy faces three main difficulties. First, it is
not sufficient simply to enumerate the deleted genes, be-
cause, for most genes, a 50% decrease in gene dosage
has no phenotypic effect. Second, mouse knockouts are
of limited use for confirmation that a gene causes human
cognitive or behavioral effects, making it difficult to test
the hypotheses generated. Finally, the gene-dosage effects
that cause these phenotypes are often dependent on ge-
netic background, reducing the value of single clinical
cases and making cross-species comparisons particularly
unreliable. Williams syndrome (WS) provides a good
example of the progress and problems in the use of mi-
crodeletion phenotypes to define genes affecting human
cognition and behavior.
WS (MIM 194050) is rare (frequency 1/20,000), with
particularly striking cognitive and behavioral features
(Morris et al. 1988). The full intelligence quotient (IQ)
of persons with WS is usually in the 50s to 60s (range
40–85). However, this camouflages a very uneven cog-
nitive profile: people with WS show relatively good ver-
bal abilities alongside very deficient visuospatial abilities
(Udwin and Yule 1991; Bellugi et al. 1994; Jarrold et
al. 1998). This differential pattern of abilities has been
termed the “WS cognitive profile” (WSCP) (Frangiskakis
et al. 1996; Mervis et al., in press). The formal definition
of WSCP is shown in the Appendix; note that it is in-
dependent of IQ or overall ability levels. Furthermore,
despite low IQ, the ability of individuals with WS to
recognize faces falls within the normal range on certain
standardized tests, such as the Benton Face Processing
Task (Bellugi et al. 1994) and the Rivermead FaceMem-
ory Test (Udwin and Yule 1991). However, the cognitive
process by which these behavioral scores are achieved
may, in fact, be different in persons with WS versus
normal controls (Karmiloff-Smith 1997). Children and
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Figure 1 A, Patients PM (left) and TM (right) with their father, from whom they inherited their deletion. B, Patient CS. All subjects
lack the dysmorphic features typical of WS.
adults with WS also have characteristic personality
traits, preferring the company of adults to that of peers
and lacking shyness toward strangers (Einfeld et al.
1997; Karmiloff-Smith et al. 1995). Physically, there is
growth retardation, a characteristic face, a high fre-
quency of supravalvular aortic stenosis (SVAS),
and, sometimes, severe infantile hypercalcemia and
hyperacusis.
WS is caused by a chromosomal deletion at 7q11.23
(Lowery et al. 1995; Nickerson et al. 1995). This chro-
mosomal region is highly repetitive, and the deletion
arises from recombination between misaligned repeat se-
quences flanking the WS region (Baumer et al. 1998).
The deletion breakpoints cluster within the repeats, so
that most patients with WS have similar, although not
identical, deletions of ∼1.5 Mb (M. Tassabehji, unpub-
lished data). The first deleted gene identified in the crit-
ical region was that for elastin (ELN) (Ewart et al.
1993a). Studies of patients having deletions or point
mutations confined to this gene show that hemizygosity
for ELN causes SVAS but not the other typical features
of WS. Several other genes have now been identified
(Osborne et al. 1996, 1997; Peoples et al. 1996; Tas-
sabehji et al. 1996; Wang et al. 1997) that are deleted
in most patients with WS, but no phenotype has been
assigned to them; these include LIMK1 (Tassabehji et
al. 1996), which codes for a protein tyrosine kinase ex-
pressed in the developing brain; that for syntaxin 1A
(STX1A) (Osborne et al. 1997), which encodes a com-
ponent of the synaptic apparatus); RFC2 (Peoples et al.
1996), which codes for a subunit of the replication fac-
tor–C complex involved in DNA replication; and FZD3
(Wang et al. 1997), which is homologous to the Dro-
sophila tissue-polarity gene, “frizzled.” To define the
roles of these other genes in the WS phenotype, we per-
formed molecular and psychometric analysis of several
persons with partial WS deletions that cause hemizy-
gosity for only some of the genes deleted in WS. Fran-
giskakis et al. (1996) have reported that patients from
two families with deletions of only ELN and LIMK1
show the characteristic WSCP, generally without mental
retardation, and the main objective of our study was to
test the generality of this observation. Thus, our psy-
chometric testing followed exactly the same procedures
as those reported by Frangiskakis et al. (1996), apart
from necessary adjustments to allow for testing of British
rather than American subjects (see the Patients and
Methods and Discussion sections). We found no evi-
dence to support the claim that haploinsufficiency for
LIMK1 (or for any of the other genes that we tested) is
implicated in the WSCP as defined by Mervis et al. (in
press). We were also able to investigate the contribution




PM was seen at age 29 years (fig. 1A). He belongs to
a family showing autosomal dominant uncomplicated
SVAS, which he inherited from his father. A cardiac mur-
mur was noted at age 3 mo. Echocardiography had
shown mild SVAS, and he was no longer under follow-
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up. He had no history of hypercalcemia, and hearing
and vision were normal. Bilateral inguinal-hernia repairs
were done at age 3 years. Early developmental mile-
stones were normal, although he attended special edu-
cation classes and obtained no formal qualifications. He
is employed in manual work. His growth was normal,
and he has no dysmorphic features. Voice quality was
normal, and there was no subjective hyperacusis. There
was no history of joint problems.
TM (the brother of PM) was seen at age 26 years (fig.
1A). A cardiac murmur was noticed shortly after birth
and subsequently was diagnosed as mild SVAS. He had
no history of hypercalcemia, and developmental mile-
stones were within normal limits. He attended main-
stream school but left without formal qualifications. He
had no history of hyperacusis or joint problems, and
eyesight, voice quality, and hearing were normal. He had
an inguinal-hernia repair as an adult. Benign glycosuria
had been noted on a number of occasions, but he was
otherwise in good health. Growth was normal, and there
were no dysmorphic features.
CS was seen at age 7 years 8 mo (fig. 1B). She was
born at term and weighed 2.7 kg. Although she was
constipated as an infant, there was no documented his-
tory of hypercalcemia, hyperacusis, or joint problems.
Developmental milestones were within normal limits.
Her mother tongue is English, but at the time of ex-
amination she was attending mainstream school in
France and was functioning bilingually, with lessons con-
ducted in both English and French. She underwent sur-
gery, at age 4 years, for severe SVAS and peripheral pul-
monary arterial stenosis but had otherwise been in good
general health. At the time of examination her height
was at the 3d–10th centile, and head circumference was
at the 10th centile. She did not have the dysmorphic
features of WS, and, apart from her surgical scar, ex-
amination results were normal. Her parents did not re-
port problems with hyperactivity or concentration.
HG, a Greek university student, was seen at age 19
years. He had a normal birth, but SVAS had been di-
agnosed during childhood and had been surgically re-
paired at age 7 years. He had no other medical problems.
Growth, development, and hearing were normal, and
there were no dysmorphic features. There was no history
of hyperacusis, and voice quality was normal. For a full
description of this subject, see the report by Frysirra et
al. (1997). Although we were unable to complete psy-
chometric testing on subject HG, he was included in the
study for purposes of investigating the physical pheno-
type of WS.
Microsatellite Analysis
Standard PCR conditions were applied: 2 min of de-
naturation at 94C, followed by 27 cycles of 94C for
1 min, 55C for 1 min, and 72C for 1 min, with a 5-
min extension at 72C. Reactions (25 ml) were set up
with 50 ng of genomic DNA, 10 pmol of each primer,
and 0.5 U Taq polymerase (BCL) in the manufacturer’s
buffer. The PCR products were run on an 8% poly-
acrylamide gel (acrylamide:N,N′ methylene bisacrylam-
ide 19:1, 300 V, 2 h), then were visualized by silver
staining.
FISH Using Cosmid Clones
Metaphase spreads of chromosomes from patients
TM, PM, CS, and HG were prepared from Epstein-Barr
virus–transformed lymphoblastoid cell lines, by stan-
dard techniques. FISH was performed as described else-
where (Tassabehji et al. 1996), with cosmid probes con-
taining ELN, LIMK1, and STX1A. A cosmid mapping
to chromosome 7p was used both to identify the chro-
mosome 7 homologues and as an internal control in each
case.
Somatic Cell Hybrids
Hybrid cell lines were isolated after lymphoblastoid
cells from the patients were fused with mouse BW5147
cells, as described elsewhere (Tassabehji et al. 1996). The
presence of a single chromosome 7 in all cell lines was
verified by FISH analysis of interphase nuclei, by means
of a chromosome 7–specific centromeric probe (Oncor),
and on metaphase chromosomes, by means of a human
chromosome 7–specific paint (Cambio). Hybrids con-
taining normal and deleted chromosomes were differ-
entiated by FISH (WSCR elastin probe; Oncor) and mi-
crosatellite typing, by means of LIMK1GT (Mari et al.
1998), with D7S653 as a control.
Deletion Mapping of Hybrids by PCR
Primers were designed for PCR analysis of somatic
cell hybrids by means of the published ELN (Tassabehji
et al. 1997), LIMK1 (Tassabehji et al. 1996), STX1A
(Osborne et al. 1997), and FZD3 (Wang et al. 1997)
cDNA sequences, as well as D7S489 (Gyapay et al.
1994). We used 50 ng of DNA, 10 pmol of each primer,
and 0.5 U of Taq polymerase (BCL) with the manufac-
turer’s buffer, in a 20-ml reaction. PCR conditions were
as follows: 2 min denaturation at 94C, followed by 30
cycles of 94C for 1 min, 60C for 1 min, and 72C for
1 min, with a 5-min extension at 72C.
Cognitive/Behavioral Assessment
For psychometric testing, we used the British Abilities
Scale (BAS-II) (Elliott 1997). We used six core subtests
(matrices, quantitative reasoning, similarities, word def-
initions, recall of designs, and pattern construction) plus
digit recall. These are the same tests as had been used
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Figure 2 Map of WS critical region, showing approximate size and extent of deletions in the patients with SVAS and in typical subjects
with WS. The distance between D7S653 and D7S489A is ∼2.5 Mb.
Figure 3 PCR analysis of hybrids for deletion of genes in the
WS region. a, FZD3 5′ end. b, FZD3 3′ end. c, STX1A 5′ end. d,
STX1A 3′ end. e, ELN exon 1. f, ELN exon 34. g, LIMK1 5′ end. h,
LIMK1 3′ end. i, D7S613. j, D7S2472. k, D7S489 (repeated at three
loci on 7q; the order is cen–D7S489M,D7S489U,D7S489L–tel).Lanes
1, PM. Lanes 2, CS. Lanes 3, HG. Lanes 4, Typical patient with WS.
Lanes 5, Control. An internal PCR control was included in each re-
action (upper band). In each gel, the PCR product expected is indicated
by an arrowhead. CS is deleted for D7S489U, FZD3, STX1A, ELN,
LIMK1, and D7S613; PM is deleted for LIMK1 and part of ELN;
HG is deleted for ELN, LIMK1, and D7S613.
by Frangiskakis et al. 1996). As in their study, for sub-
jects 118 years old we used the norms for the oldest age
group in the standardization sample (17 years 6 mo–17
years 11 mo). This is consistent with the procedure for
the determination of subscale standard scores for the
adult version of the Wechsler (1981) test. Raw scores
were converted to T scores.
Results
Deletion Mapping Using Microsatellite Markers
Microsatellite mapping of the DNA of patients with
SVAS and of their parents, by use of nine markers span-
ning a distance of 3 cM (seven Ge´ne´thon primers [Gya-
pay et al. 1994] plus microsatellites from intron 18 of
ELN [Foster et al. 1993] and from intron 13 of LIMK1
[Mari et al. 1998]) allowed the initial definition of the
deletion breakpoints. Patients PM and TM were hetero-
zygous for all of the markers tested, apart from LIMK1
and ELN, suggesting that any deletion was very small.
Subjects CS and HG had larger deletions compared with
those in TM and PM (fig. 2). The sizes of the deletions
were estimated by use of markers from a physical map
of the region (M. Tassabehji, unpublished data).
Deletion Analysis by FISH
FISH analyses were done on subjects PM, TM, CS,
and HG by use of cosmids containing LIMK1, ELN,
and STX1A (data not shown). One copy of LIMK1 was
deleted in all four subjects. ELN was deleted in HG and
CS, but in PM and TM both chromosomes gave a FISH
signal, suggesting that the gene was either not deleted
or only partially deleted. STX1Awas deleted only in CS.
Deletion Mapping by PCR of Somatic Cell Hybrids
Because partially deleted genes can give detectable
FISH signals, somatic cell hybrid lines were made from
cells of subjects CS, HG, and TM, to allow their deletion
breakpoints to be more finely mapped. The normal and
deleted copies of chromosome 7 were segregated, and
stable cell lines were established. Hybrids containing the
deleted chromosome 7 from each person were tested for
the presence of FZD3, STX1A, ELN, LIMK1, and
RFC2, by PCR using primers designed to amplify the 5′
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Table 1




Recall of designs 38 49 57
Pattern construction 49 52 54
Matrices 27 57 67
Quantitative reasoning 20 57 55
Similarities 40 50 53
Word definitions 58 45 60
Mean 38.7 51.7 57.7
Digit recall 32 48 49
Standard tests:
Verbal 98 96 110
Nonverbal reasoning 55 111 118
Spatial 88 100 115
GCA 77 103 115
Criterion:
Fit to WSCP
1 No No Yes
2 No No No
3 No No No
4 Yes Yes Yes
a Results of testing using BAS-II; for subtests, T scores are given.
and 3′ regions of the genes. A marker, D7S639, known
to map outside the deleted region was included as a
positive control in the PCR reaction. Mouse DNA was
also included as a control, to show that the PCR-am-
plification products were human specific.
The results (fig. 3) show that the entirety of LIMK1
is deleted in each subject, confirming the FISH results.
In TM, the deletion included part of ELN from exon
10 onward but did not include either RFC2 or STX1A.
HG has a larger deletion that includes the entirety of
both ELN and LIMK1 but none of either RFC2 or
STX1A. CS has a larger deletion that includes FZD3,
STX1A, ELN, LIMK1, and RFC2; her deletion extends
to D7S489U(B). The marker D7S489 is present at three
loci on chromosome 7q (D7S489M[A], D7S489U[B],
and D7S489L[C]), and D7S489U(B) is deleted in most
patients withWS (fig. 2). The deletion in CS thus appears
to include all of the WS critical region proximal to ELN.
Cognitive/Behavioral Assessment
Subjects were tested by means of BAS-II (Elliott 1997).
Because valid administration of BAS-II tests requiresme-
ticulous adherence to protocols and timing, we were
unable to obtain data for HG, the Greek student, whose
English was very poor despite his high intelligence. Table
1 shows the results of the BAS-II subscales for the re-
maining three subjects—PM, TM, and CS. We used the
same tests (six core subtests plus digit recall) as had been
used by Frangiskakis et al. (1996). These tests included
two spatial-construction tasks (recall of designs and pat-
tern construction), two nonverbal-reasoning tasks (ma-
trices and quantitative reasoning), and two verbal tasks
(similarities and word definitions). Figure 4 illustrates
the performances of CS and TM on the recall-of-designs
task, compared with two age-matched patients withWS.
Globally, PM performed more poorly than did either
TM or CS. In view of the differential abilities and the
four criteria (Appendix) that are combined to specify the
WS cognitive/behavioral profile, only CS met criterion
1. No subject met either criterion 2 or criterion 3. All
subjects met criterion 4, as expected of normal subjects.
Thus, none of our three subjects met the WSCP, despite
their LIMK1 deletions. BAS-II allows standard scores
(mean 100, SD 15) to be derived both for clusters of
subtests (verbal, nonverbal reasoning, and spatial) and
overall (the latter is termed “general conceptual ability”
[GCA]). GCA is close to what other tests call “IQ.” The
standard scores are also shown in table 1. Subject PM’s
GCA is at the low end of the normal range, because of
poor nonverbal nonspatial reasoning. When his verbal
and spatial scores are compared, he does not have the
WSCP. It is not likely that his overall poor score is in
any way related to his chromosomal deletion, because
none of the other subjects scored poorly.
Discussion
Chromosome 7 deletions causing WS remove a num-
ber of genes; but determining which gene is responsible
for which part of the phenotype is not simple. Mouse
knockouts may not be very informative, because there
is not always a consistent homology between mouse and
human phenotypes for haploinsufficiency syndromes,
whereas genetic background often has a large modifying
effect. For example, haploinsufficiency for PAX3 causes
dystopia canthorum; pigmentary abnormalities of the
skin, hair, and eyes; and frequent hearing loss in humans
(type 1 Waardenburg syndrome); however, the same ge-
netic change in mice causes no hearing loss and just a
white belly splotch (Read et al. 1997). When the phe-
notype in question is behavioral, the difficulties are com-
pounded. Thus, unraveling the cognitive and behavioral
components of WS is likely to rely heavily on studies of
individuals with partial deletions and/or partial WS. In
the present study, such persons were identified on the
basis of a single feature of WS—SVAS—which demon-
strates a general strategy for disentangling the compo-
nents of complex phenotypes.
Haploinsufficiency for elastin accounts for the SVAS
in patients with WS. Keating’s group showed that dom-
inant isolated SVAS maps to 7q11 (Ewart et al. 1993b).
Subsequently, they and we have described loss-of-func-
tion mutations in ELN in many persons with uncom-
plicated SVAS (Li et al. 1997; Tassabehji et al. 1997).
Although it had seemed plausible that a deficiency of
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Figure 4 Examples of visuospatial deficiency in patients with WS and of its absence in subjects CS and TM. Subjects were shown a
drawing (BAS-II model) and were asked to reproduce it immediately afterward, from memory (BAS-II recall-of-designs task). a, Reproductions
by CS (i) and by a linguistically able patient with WS, age 9 years 10 mo (ii). b, Reproductions by TM (i) and by a linguistically able patient
with WS, age 29 years 7 mo (ii).
this connective-tissue protein might also cause the char-
acteristic WS face, patients with mutations or deletions
of ELN do not have this appearance (fig. 1), which must
therefore be caused by other genes within the WS de-
letion. In the present study, two of the four patients with
SVAS had inguinal hernias, and, since hernias occur in
∼30% of our patients with WS (K. Metcalfe, unpub-
lished data), it is possible that haploinsufficiency for elas-
tin may be responsible for this. No other WS feature is
seen in patients with isolated ELN deficiency.
The most intriguing feature of WS is the cognitive and
behavioral phenotype, which is striking and highly pen-
etrant. The WSCP is one aspect of this. The WSCP de-
scribes the relative levels of several abilities, not their
absolute level, and is defined in terms of relative per-
formance on different subtests of the Differential-Abil-
ities Scale (DAS) (Elliott 1990), on the basis of the four
criteria listed in the Appendix (Frangiskakis et al. 1996;
Mervis et al., in press). The BAS-II scale that we used
is the British equivalent of the DAS. The main difference
between the two scales is in the verbal-similarities sub-
test, where items relevant to American culture are re-
placed with items relevant to British knowledge; both
types of items have been normed on large American and
British populations, respectively. These tests are designed
both to provide specific information about strengths and
weaknesses in different areas and to give an overall per-
formance level, and they can furnish differential scores
even for patients performing at low levels. Moreover,
whereas, on the Wechsler intelligence scale, individuals
with WS do not always show an advantage of verbal IQ
over performance IQ (Wechsler 1981; Udwin et al. 1987;
Bellugi et al. 1994; Karmiloff-Smith et al. 1997), the
DAS and BAS-II are particularly sensitive to the cognitive
imbalance typical of WS.
Frangiskakis et al. (1996) have identified the WSCP
in 11 of 13 people who have deletions of just ELN and
the neighboring LIMK1. Most were of normal intelli-
gence. Thus, the level of LIMK1 product might govern
specific features of cognition, rather than merely cause
mental retardation as do so many other gene defects.
LIMK1 encodes a protein tyrosine kinase that phos-
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phorylates and inactivates cofilin, a protein that is re-
quired for turnover of actin filaments (Arber et al. 1998;
Yang et al. 1998). Actin depolymerization and recycling
are required at the leading edge of a moving cellular
process, so that defects in actin turnover could affect
axonal guidance during CNS development. Since
LIMK1 is expressed at high level in the CNS (Okano et
al. 1995), it is a promising candidate for mental aspects
of theWS phenotype. However, our psychometric testing
of subjects PM, TM, and CS showed no evidence of the
WSCP. As explained above (see the Cognitive/Behavioral
Assessment subsection in the Results section), we were
unable to obtain valid BAS-II scores for the Greek sub-
ject, HG, because of his poor command of English.
Our data suggest either that LIMK1 deletion is irrel-
evant to the WSCP or that, at most, it is necessary but
not sufficient. It could be argued that WSCP, as a hap-
loinsufficiency effect, is likely to have reduced pene-
trance, but, in patients with WS, the penetrance is not
low; the WSCP is a near-universal feature of WS. This
is not an artifact due to biased ascertainment: patients
with WS are identified on the basis of various combi-
nations of heart problems, hypercalcemia, developmen-
tal delay, and facial appearance but not on the basis of
their cognitive profile, which emerges only after careful
psychometric testing. Yet, almost every person diagnosed
with WS has the WSCP. The cases reported by Frangis-
kakis et al. (1996) all came from two families, so they
represent the effects of only two different deletions. The
determinant of the WSCP must map within the WS crit-
ical region, since deletion of this region is the only genetic
factor common to all patients with WS. Thus, it is pos-
sible that the WSCP could cosegregate in a family with
a LIMK1 deletion, without the deletion itself being the
cause. Perhaps this unstable chromosomal region is
prone to complex rearrangements, including noncontig-
uous deletions.
One patient, CS, also had deletions for FZD3,
STX1A, and RFC2, suggesting that the determinants of
all aspects of the WS phenotype, apart from SVAS, lie
telomeric to RFC2. However, identification of further
individuals with partial deletions would provide a val-
uable resource to confirm this and to help delineate the
full spectrum of genes that contribute to the WS
phenotype.
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Appendix
Criteria for WSCP
1. Pattern-construction T score less than mean T score
for six core subtests
2. Pattern-construction T score less than digit-recall
T score
3. Pattern-construction T score below the 20th
percentile
4. T score, for either digit recall, naming-definitions,
or similarities, above the 1st percentile
The WSCP is defined in terms of the relative, not ab-
solute, levels of abilities and is independent of general
intelligence. WSCP is present if all four criteria are met;
normal subjects are expected to fulfill only criterion 4.
Electronic-Database Information
Ge´ne´thon, http://www.genethon.fr (for microsatellite markers)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for WS [MIM 194050])
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